About the Authors

Martin Bergbauer

Affiliation Department of Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany

Markus Kalla

Affiliation Department of Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany

Anne Schmeinck

Affiliation Department of Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany

Christine Göbel

Affiliation Department of Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany

Ulrich Rothbauer

Affiliation Biocenter at the Department of Biology II, Ludwig-Maximilians University Munich, Martinsried, Germany

Sebastian Eck

Affiliation Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany

Anna Benet-Pagès

Affiliation Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany

Tim M. Strom

Affiliation Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany

Wolfgang Hammerschmidt

hammerschmidt@helmholtz-muenchen.de

Affiliation Department of Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany

Competing Interests

U.R. is one of the founders and shareholders of ChromoTek, which is developing GFP-specific nanobodies for in vitro and in vivo applications used in this manuscript.

Author Contributions

Conceived and designed the experiments: MB MK WH. Performed the experiments: MB MK AS CG ABP. Analyzed the data: MB AS SE TMS WH. Contributed reagents/materials/analysis tools: UR SE. Wrote the paper: WH.